mpathic AI
Facts
Is this your organization? Claim it
mpathic CEO Dr. Grin Lord Says AI Conversation Analytics Achieved PMF in Psychedelic Trials but $6B TAM Prompted Strategic Expansion
Dr. Grin Lord explains that mpathic found product-market fit with its AI conversation analytics—especially in psychedelic medicine trials where it automates review of patient recordings—but faced limits to venture-scale growth from a ~$6B TAM and chose to expand into adjacent clinical-trial markets informed by customer feedback.
